Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PJP vs XPH overlap: 18% of top holdings shared

Bottom line

How much do PJP and XPH overlap?

18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 23.2% of PJP's assets and 10.6% of XPH's. They are substantially different portfolios, so owning both adds real diversification.

XPH holds far more positions (67 vs 33), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PJPXPH
Weight overlap (top 25)18%
Shared holdings6
Weight in shared holdings23.2%10.6%
Total positions3367
Expense ratio0.58%0.35%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings PJP and XPH have in common

Holding% of PJP% of XPHOverlap
Merck & Co., Inc.5.06%1.65%1.65%
Corcept Therapeutics Inc.4.96%1.70%1.70%
Amneal Pharmaceuticals, Inc.3.75%1.72%1.72%
Liquidia Corp.3.66%1.86%1.86%
Ligand Pharmaceuticals Inc.3.20%1.94%1.94%
Ocular Therapeutix, Inc.2.58%1.71%1.71%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PJP

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Eli Lilly and Co. — 5.02%
  7. Gilead Sciences, Inc. — 4.53%
  8. Pfizer Inc. — 4.50%
  9. Invesco Private Government Fund — 3.73%
  10. Travere Therapeutics, Inc. — 3.30%
  11. Regeneron Pharmaceuticals, Inc. — 3.14%
  12. Harmony Biosciences Holdings, Inc. — 3.06%
  13. Bristol-Myers Squibb Co. — 2.94%
  14. Viatris Inc. — 2.83%
  15. Jazz Pharmaceuticals PLC — 2.79%

Only in XPH

  1. State Street Global Advisors — 8.58%
  2. Definium Therapeutics Inc — 3.09%
  3. MBX Biosciences Inc — 2.72%
  4. Alumis Inc — 2.14%
  5. AtaiBeckley Inc — 2.13%
  6. Trevi Therapeutics Inc — 2.12%
  7. Enliven Therapeutics Inc — 2.09%
  8. Amylyx Pharmaceuticals Inc — 2.04%
  9. VeraDermics Inc — 2.02%
  10. Nuvation Bio Inc — 1.89%
  11. Edgewise Therapeutics Inc — 1.88%
  12. Nektar Therapeutics — 1.88%
  13. Maze Therapeutics Inc — 1.85%
  14. Harrow Inc — 1.81%
  15. EyePoint Inc — 1.77%

Asset mix

Asset typePJPXPH
Stocks99.9%100.0%
Cash & short-term funds11.8%8.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryPJPXPH
US106.5%98.4%
IE5.2%3.0%
CA—3.1%
GB—1.6%
SG—1.6%
KY—1.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PJP and XPH overlap?
About 18% by weight. 6 securities appear in both funds' top 25 holdings; they make up 23.2% of PJP's assets and 10.6% of XPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PJP and XPH have in common?
The largest shared holdings are Ligand Pharmaceuticals Inc., Liquidia Corp., Amneal Pharmaceuticals, Inc., Ocular Therapeutix, Inc., Corcept Therapeutics Inc..
Should I own both PJP and XPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PJP or XPH?
XPH is broader, with 67 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.